Mosaic ImmunoEngineering (CPMV) Price to Earnings (2013 - 2026)

Mosaic ImmunoEngineering has reported Price to Earnings for 14 years, with the latest figure at 30.98 in Q1 2026.

• On a quarterly basis, Price to Earnings rose 0.57% year-over-year to 30.98 in Q1 2026; TTM through Mar 2026 was 7.97, a 14.9% decrease from a year earlier, with the FY2025 full-year figure at 3.26, up 40.64% from the prior year.
• Price to Earnings was 30.98 for Q1 2026 at Mosaic ImmunoEngineering, down from 13.27 in the prior quarter.
• The five-year high for Price to Earnings was 369.27 in Q2 2023, with the low at 43.36 in Q3 2022.
• Average Price to Earnings over 5 years is 1.89, with a median of 14.7 recorded in 2023.
• The sharpest annual moves came in 2022 and 2023: Price to Earnings plunged 319.06% in 2022, then jumped 2733.76% in 2023.
• Over 5 years, Price to Earnings stood at 13.42 in 2022, then declined by 9.52% to 14.7 in 2023, then slumped by 125.31% to 33.12 in 2024, then surged by 59.93% to 13.27 in 2025, then sank by 133.36% to 30.98 in 2026.
• The last three Price to Earnings figures came in at 30.98 (Q1 2026), 13.27 (Q4 2025), and 30.66 (Q3 2025), per Business Quant data.